Dr. Adam Boxer speaks at the NAPA listening session in San Francisco
Leave a comment below to let us know about the everyday heroes in your life! In honor of Alzheimer’s Action Day on September 21, we are highlighting 21 Everyday Heroes. Today, meet our 14th hero Adam Boxer, MD, PhD, who directs studies of new therapeutic agents for Alzheimer’s disease and frontotemporal dementia with the UCSF Memory and Aging Center. Dr. Boxer made his voice heard at the NAPA listening session in San Francisco in August and he continues to be a strong advocate for Alzheimer’s families. He says “Although we are making progress on new technologies to diagnose dementia more accurately and at earlier stages, as well as new therapies that may potentially slow the progression of Alzheimer’s disease, such new technologies will be very expensive, and have the potential to greatly exacerbate the rise in US healthcare costs.” Listen to all of Dr. Boxer’s comments from the NAPA listening session at about the 54-minute mark of this video from the event: San Francisco Listening Session and read about Dr. Boxer and his work here: Bio for Dr. Adam Boxer. Learn more about how you can raise awareness of Alzheimer’s disease at www.alz.org/wam.
